VRAX viraxbiolabs.com: Prakiraan wutah bathi saben saham kanggo taun ngarep

Logo perusahaan publik Virax Biolabs Group (VRAX)

The T-cell analysis ecosystem retains B2B clients through proprietary reagents but suffers from a post-pandemic exodus. Falling demand for virus diagnostics has crashed sales and free cash flow. The consensus estimate for net profit growth rates visualizes these trends, where the 0.00 metric reflects current dynamics. Meanwhile, portable laboratories allow Virax Biolabs Group (VRAX) to exercise pricing power due to the speed of primary tests.

VRAX: Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Virax Biolabs Group Ltd 28.04.2023 - 16.11.2026

Rincian analitis lan laporan data perusahaan Virax Biolabs Group Ltd (VRAX)

- rega lan prakiraan konsensus rega:
Analisis umum perusahaan:Virax Biolabs Group
Produk dadi Virax Biolabs Group Limited

Virax Biolabs Group (VRAX) maintains liquidity through the sale of diagnostic panels, which fully funds its current R&D research. By analyzing the trend of consensus EPS forecasts for the coming year, an investor assesses aggregated expert expectations for net cash flow over the next four quarters, allowing for a comparison of market optimism with the issuer's actual financial stability and fundamental ability to generate profit.

Analisis pesaing Virax Biolabs Group

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Biotechnology - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep soterahealth.com|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPKO Health - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|XGN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MDxHealth Inc. - Proyeksi tambahing bathi saben saham ing taun ngarep|LUCD: Prakiraan wutah bathi kanggo taun ngarep|Prenetics Global Limited - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep Ainos Corp (AIMD)|Prakiraan wutah bathi kanggo taun ngarep CODX (codiagnostics.com)|Heart Test Laboratories - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Biomerica Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Cardio Diagnostics Holdings|ONCO (Onconetix Corporation) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|AXDX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep centogene.com (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Enzo Biochem|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep FRES|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep GTG Labs|23andMe Holding Co - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep